No trading signal from this routine governance filing. Monitor for any future executive departures or change-in-control events that could trigger severance payments.
XNCR drugs
XNCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 28 $12.15entry
- T+1 · 7mo ago −4.20%α −4.19% · $11.64
- T+5 · 7mo ago +9.96%α +8.27% · $13.36
- T+20 · 6mo ago −4.28%α −9.75% · $11.63
- T+60 · 4mo ago +60.74%α +56.75% · $19.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Xencor adopted an Executive Severance Policy covering VPs and above (excluding CEO), providing lump-sum base salary (15 months for EVPs/NEOs), COBRA premiums, and double-trigger change-in-control benefits. This is a routine compensatory arrangement with no immediate financial impact or executive changes.
Key Facts
- Severance policy adopted on April 23, 2026, covering Vice Presidents and above (excluding CEO)
- Standard termination provides lump sum of 15 months base salary for EVPs/NEOs plus COBRA premiums
- Change-in-control termination adds 15 months target bonus, prorated annual bonus, and full equity acceleration
- No executive departures, appointments, or financial data disclosed
Financial Impact
No immediate financial impact; potential future severance obligations not quantified
Risk Factors
- Potential future severance costs if executives are terminated without cause or resign for good reason
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001326732-26-000030 |
| Document: xncr-20260423.htm | 0001326732-26-000030 |
| Document: 0001326732-26-000030-index-headers.html | 0001326732-26-000030 |
| Document: 0001326732-26-000030-index.html | 0001326732-26-000030 |
| Document: 0001326732-26-000030.txt | 0001326732-26-000030 |
Track record
20 reports on XNCR
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
- Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers